Today, patients want to know more about new treatment options as they come to market, and be more engaged in their treatment decisions, receive more personalized healthcare and, ultimately, feel confident that they’re receiving the best treatment. This means that launching new products in this evolving environment will require launch teams from pharmaceutical companies to… Read article →
Shibani Datta is a Global Market Manager in Demand Generation at QIAGEN. She has received her education in the field of Genetics from Texas A&M University, where she studied the mechanisms of DNA replication and amplification in Tetrahymena thermophila. Prior to her marketing role, she has trained as a biotechnologist in the field of assay development, antibody generation, and humanization. She is passionate about communicating the value of molecular technologies for research and healthcare.